Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Open access

 

Report: Recession failed to force healthcare reform

How did the crash hit European public healthcare systems? Seven years on, an exhaustive new book by a dozen academics, Economic Crisis, Health Systems and Health in Europe, suggests the deep recession has had little impact. The book’s 500 pages narrow down on how countries responded to the crisis. Interestingly, when Healthcare Europa looked at […]

Capio’s IPO – test balloon or crash test dummy?

Capio, the Swedish, German and French hospital group, owned mainly by Apax and Nordic Capital, is to float 25-37.5% of its shares on the Swedish NASDAQ at a fixed price of SEK48.5. The multiple looks low. That reflects political uncertainty and low EBITDA margins. The IPO will be closely watched by other large Swedish private healthcare groups. Read on for our analysis.

Cofinimmo increases its German footprint

Belgian healthcare real estate investment trust Cofinimmo has tripled its investments in Germany with the purchase and leaseback of two high-end wellness and sport centres from the Aspria Group. We speak to Cofinimmo CEO, Jean-Edouard Carbonnelle about the deal.

All change in the French lab space

Biomnis and Bio-Access are both close to getting new owners. That will herald the arrival on the scene of a major quoted industrial.

Amedes could sell fast

We hear talks to sell German/Belgian lab group amedes are far advanced, and not to private equity.

Find Us